Interchangeability of generic drugs for subpopulations: bioequivalence simulation from a non-parametric PK model of gabapentin generic drugs.

Our simulations indicate that the reduced likelihood of demonstrating bioequivalence for subjects with altered pharmacokinetics is not influenced by a formulation switch, nor does the average comparable bioavailability ratio change. Therefore, these results support generic interchangeability and current approval requirements for generics.